Top Stories

Pfizer CEO confirms coronavirus vaccine trial may have results in October


In this May 4, 2020 photo provided by the University of Maryland School of Medicine, the first patient enrolled in Pfizer’s COVID-19 coronavirus vaccine clinical trial at the University of Maryland School of Medicine in Baltimore, receives an injection.

University of Maryland School of Medicine | AP

Pfizer could have results from its late-stage coronavirus vaccine trial as early as October, CEO Albert Bourla said Thursday.

The pharmaceutical company has already enrolled 23,000 volunteers in the phase three trial that began in late July, Bourla said during a Q&A with the International Federation of Pharmaceutical Manufacturers & Associations, a trade group. It hopes to enroll at least…


Chinese banks’ profits will weaken further in second half of 2020, Fitch says

Previous article

Sweden adopted a controversial approach to tackling the coronavirus. Here’s how it plans to save Christmas

Next article

You may also like

Leave a Reply

Notify of

More in Top Stories